Stifel Financial
IART icon

Stifel Financial’s Integra LifeSciences IART Stock Holding History

Stifel Financial’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,760
Closed -$204K – 3410
2024
Q1 		$204K Buy
5,760
+252
+5% +$10.1K ﹤0.01% 3088
2023
Q4 		$240K Sell
5,508
-203
-4% -$7.99K ﹤0.01% 2973
2023
Q3 		$218K Buy
+5,711
New +$240K ﹤0.01% 2948
2019
Q3 		– Sell
-6,038
Closed -$336K – 2904
2019
Q2 		$336K Buy
+6,038
New +$311K ﹤0.01% 2437
2018
Q3 		– Sell
-9,613
Closed -$622K – 2787
2018
Q2 		$622K Buy
+9,613
New +$595K ﹤0.01% 1904

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Stifel Financial's IART Position: Q2 2024 in Review

Stifel Financial sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 5,760 shares — an estimated $204K sold.

Stifel Financial first reported a position in IART in Q2 2018 and held it in 5 quarters. The position peaked at $622K in Q2 2018. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • Stifel Financial reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Stifel Financial sold 5,760 Integra LifeSciences shares in Q2 2024, an estimated $204K.
  • Stifel Financial first reported a position in Integra LifeSciences in Q2 2018 and held it in 5 quarters.
  • Stifel Financial's Integra LifeSciences position peaked at $622K in Q2 2018.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Stifel Financial's 13F filing for Q2 2024, filed 13 Aug 2024.